Table 4.
Blood PO2 and PCO2 during the CP experimental trials
| Variables | PLN | ALN | PLH | ALH |
|---|---|---|---|---|
| Pre-supplement PCO2 (kPa) | 5.3 ± 0.5 | 5.5 ± 0.5 | 5.1 ± 0.6 | 5.4 ± 0.6* |
| Pre-exercise PCO2 (kPa) | 5.8 ± 0.3 | 5.7 ± 0.2 | 5.4 ± 0.4 | 5.7 ± 0.5 |
| Post-exercise PCO2 (kPa) | 5.2 ± 0.4 | 5.4 ± 0.5 | 5.1 ± 0.5 | 5.4 ± 0.5* |
| Pre-supplement PO2 (kPa) | 9.0 ± 1.5 | 8.7 ± 1.3 | 8.3 ± 1.5 | 8.3 ± 2.0 |
| Pre-exercise PO2 (kPa) | 8.2 ± 1.3 | 8.6 ± 0.9 | 8.3 ± 1.7 | 8.5 ± 2.1 |
| Post-exercise PO2 (kPa) | 9.0 ± 3.7 | 10.0 ± 2.1 | 9.0 ± 2.0 | 7.6 ± 1.4 |
PLN represents the placebo normoxia condition, ALN represents the alkalosis normoxia condition, PLH represents the placebo hypoxia condition, ALH represents the alkalosis hypoxia condition
*Denote significant difference from placebo condition in the same environmental condition